about
ImmunityBio Inc is an integrated clinical-stage biotechnology company discovering, developing, and commercializing next-generation immuno- and cellular therapies that bolster the natural immune system to drive and sustain an immune response. Its plat...
Read More
2.56
0.02
(0.79%)
7.1M
XNAS Volume
XNAS 30 Jul, 2025 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
ImmunityBio Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..